LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes.
Reibaldi Michele, Avitabile Teresio, Russo Andrea, Bonfiglio Vincenza, Mariotti Cesare, Romano Mario R, Boscia Francesco, Cennamo Gilda, Fallico Matteo, Parisi Guglielmo
AI Summary
This study found late-onset ocular hypertension occurred in 4.9% of vitrectomized eyes, primarily linked to intraoperative triamcinolone and post-vitrectomy pseudophakia/aphakia, highlighting the need for vigilance.
Abstract
Purpose
To determine the incidence and risk factors for late-onset ocular hypertension (LOH) after vitrectomy.
Methods
From the electronic medical records of consecutive patients who underwent primary vitrectomy, from January 2010 to December 2015, at 5 tertiary vitreoretinal centers in Italy, patient demographics, systemic, ophthalmic, operative, and postoperative data were drawn. Main outcome measure was the presence of LOH, defined as intraocular pressure >21 mmHg detected more than 2 months after vitrectomy on at least 2 consecutive visits.
Results
Among 6,048 patients, LOH was found in 294 (4.9%) vitrectomized eyes and in 87 (1.4%) fellow eyes, (chi square; P < 0.001). Multivariable logistic regression showed that significant risk factors for developing LOH included intraoperative triamcinolone use (odds ratio [OR], 7.62; P < 0.001), longer axial length (OR, 1.55; P = 3.023), preoperative higher intraocular pressure (OR, 1.81; P = 0.003), and postvitrectomy pseudophakic/aphakic status (OR, 2.04; P < 0.001). Decision-tree analysis showed that the stronger predictor of LOH was intraoperative triamcinolone use (P < 0.001). Secondary predictors were a preoperative intraocular pressure more than 15 mmHg (P < 0.001) in eyes that use triamcinolone, and postvitrectomy pseudophakic/aphakic status (P = 0.007) in eyes that did not use triamcinolone.
Conclusion
Late-onset ocular hypertension occurred in 4.9% of vitrectomized eyes. The main risk factors were intraoperative use of triamcinolone and postvitrectomy pseudophakic/aphakic status.
MeSH Terms
Shields Classification
Key Concepts5
Late-onset ocular hypertension (LOH), defined as intraocular pressure >21 mmHg detected more than 2 months after vitrectomy on at least 2 consecutive visits, occurred in 4.9% of 6,048 vitrectomized eyes.
Intraoperative triamcinolone use was a significant risk factor for developing late-onset ocular hypertension after vitrectomy (odds ratio [OR], 7.62; P < 0.001) in a multicenter study of 6,048 vitrectomized eyes.
Postvitrectomy pseudophakic/aphakic status was a significant risk factor for developing late-onset ocular hypertension after vitrectomy (odds ratio [OR], 2.04; P < 0.001) in a multicenter study of 6,048 vitrectomized eyes.
Longer axial length (OR, 1.55; P = 3.023) and preoperative higher intraocular pressure (OR, 1.81; P = 0.003) were identified as significant risk factors for developing late-onset ocular hypertension after vitrectomy in a multicenter study of 6,048 vitrectomized eyes.
A multicenter retrospective cohort study of 6,048 patients who underwent primary vitrectomy between January 2010 and December 2015 at 5 tertiary vitreoretinal centers in Italy investigated the incidence and risk factors for late-onset ocular hypertension after vitrectomy.
Related Articles5
Risk factors of rejection after penetrating keratoplasty: a retrospective monocentric study.
Cohort StudyLONG-TERM FOLLOW-UP OF INTRAOCULAR PRESSURE AFTER VITRECTOMY IN EYES WITHOUT PREEXISTING GLAUCOMA.
Case SeriesIncidence of Intraocular Pressure Elevation and Glaucoma after Lamellar versus Full-Thickness Penetrating Keratoplasty.
Cohort StudyIncidence of late-onset ocular hypertension following uncomplicated pars plana vitrectomy in pseudophakic eyes.
Case SeriesIntraocular Pressure Spike Following Stand-Alone Phacoemulsification in the IRIS® Registry (Intelligent Research in Sight).
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.